Form 4 holding
Chief Medical Officer
Denali Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 216,585
- Estimated value
- $3,170,804
- Report date
- 13 Aug 2025
- Price
- $14.64
- Ownership
- Direct
Carole Ho - Chief Medical Officer at Denali Therapeutics Inc.
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- DNLI on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Carole Ho since 13 Sep 2025
Reported holdings for Carole Ho in Denali Therapeutics Inc.
Form 4 holding
Chief Medical Officer
Denali Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 25,000
- Estimated value
- $363,000
- Report date
- 12 Aug 2025
- Price
- $14.52
- Ownership
- Indirect
Form 4 holding
Chief Medical Officer
Denali Therapeutics Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 62,500
- Estimated value
- Report date
- 05 Aug 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Carole Ho in Denali Therapeutics Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.